SDX-7320
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SDX-7320, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer [Phase 2]